Found: 7
Select item for more details and to access through your institution.
Effectiveness and safety of alemtuzumab in the treatment of active relapsing–remitting multiple sclerosis: a multicenter, observational study.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 11, p. 4591, doi. 10.1007/s10072-021-05145-x
- By:
- Publication type:
- Article
Diffuse large B cell lymphoma mimics myasthenia gravis.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Psoriasis caused by ocrelizumab in two persons with primary progressive multiple sclerosis.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 9, p. e322, doi. 10.1111/ijd.16208
- By:
- Publication type:
- Article
Disease-modifying therapy for multiple sclerosis in Slovenia: analysis of 20 years of treatment.
- Published in:
- Rad Hrvatske Akademije Znanosti i Umjetnosti. Medicinske Znanosti, 2022, v. 552, n. 58/59, p. 28, doi. 10.21857/mjrl3ug069
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy in association with siponimod treatment for secondary progressive multiple sclerosis: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, p. 1, doi. 10.1177/1756286420975223
- By:
- Publication type:
- Article
Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420975223
- By:
- Publication type:
- Article